5311462026-04-012026-06-305311462026-06-305311462026-04-012026-06-30in-capmkt:OtherExpenses1Member5311462026-06-30Statement15311462026-04-012026-06-30Statement15311462026-06-30StatementDynamic1I1Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares531146MEDICAMEQNOTLISTEDINE646B01010MEDICAMEN BIOTECH LIMITEDMain BoardEquity2026-04-012027-03-312026-08-142026-08-07INRLakhsQuarterlyFirst quarterSingle segmentPharmaceuticals2026-08-1414:00:002026-08-1415:15:00Not applicabletrue1true2026-04-012026-06-30UnauditedStandalone43852700086160004471430002207920000-1490500062233000639400017438000122612000414564000325790000325790008301000-9910007310000025269000000025269000025269000135628000101.861.86001.861.86Otherc Expenses1226120002618610000000Preferential Issues2025-04-245356810002026-06-30falsefalseNANANAParul ChoudharyCompany Secretary and Compliance OfficerNew Delhi2026-08-14a) Drug Development of 50 SKUs for Regulated markets b) Registration of dossiers, etc. c) Meet the Enhanced working capital requirements d) Capital expenditure in some area of upgradation of the existing facilities e) Expansion of operations in Domestic Market f) General Corporate PurposesNA53568100003156810000